Identification of Transcriptomic Differences in Induced Pluripotent Stem Cells and Neural Progenitors from Amyotrophic Lateral Sclerosis Patients Carrying Different Mutations: A Pilot Study
Authors:
- Chiara SgromoCSChiara Sgromo
- Martina TosiMTMartina Tosi
- Cristina OlgasiCOCristina Olgasi
- Fabiola De MarchiFMFabiola De Marchi
- Francesco FaveroFFFrancesco Favero
- Giorgia VenturinGVGiorgia Venturin
- Beatrice PiolaBPBeatrice Piola
- Alessia CucciACAlessia Cucci
- Lucia CorradoLCLucia Corrado
- Letizia MazziniLMLetizia Mazzini
- Sandra D’alfonsoSDSandra D’alfonso
- Antonia FollenziAFAntonia Follenzi
Open Access
Abstract
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease affecting motor neurons with a phenotypic and genetic heterogeneity and elusive molecular mechanisms. With the present pilot study, we investigated different genetic mutations (C9orf72, TARDBP, and KIF5A) associated with ALS by generating induced pluripotent stem cells (iPSCs) from peripheral blood of ALS patients and healthy donors. iPSCs showed the typical morphology, expressed stem cell markers both at RNA (OCT4, SOX2, KLF4, and c-Myc) and protein (Oct4, Sox2, SSEA3, and Tra1-60) levels. Moreover, embryoid bodies expressing the three germ-layer markers and neurospheres expressing neural progenitor markers were generated. Importantly, the transcriptomic profiles of iPSCs and neurospheres were analyzed to highlight the differences between ALS patients and healthy controls. Interestingly, the differentially expressed genes (DEGs) shared across all ALS iPSCs are linked to extracellular matrix, highlighting its importance in ALS progression. In contrast, ALS neurospheres displayed widespread deficits in neuronal pathways, although these DEGs were varied among patients, reflecting the disease’s heterogeneity. Overall, we generated iPSC lines from ALS patients with diverse genetic backgrounds offering a tool for unravelling the intricate molecular landscape of ALS, paving the way for identifying key pathways implicated in pathogenesis and the disease’s phenotypic variability.Keywords
Funding Information
- Department of Excellence at the Department of Translational Medicine (DIMET), Università del Piemonte Orientale, Novara, Italy (FG_19_2023, 68155, 2022CAWRK5)
- DIG-ALS, AriSLA Foundation (FG_19_2023, 68155, 2022CAWRK5)
- CSP—Compagnia San Paolo Trapezio (FG_19_2023, 68155, 2022CAWRK5)
- PRIN 2022 (FG_19_2023, 68155, 2022CAWRK5)
- Bando per la Ricerca Roche 2024 (FG_19_2023, 68155, 2022CAWRK5)
This publication has 42 references indexed in Scilit:
- Sporadic ALS hiPSC-derived motor neurons show axonal defects linked to altered axon guidance pathwaysNeurobiology of Disease, 2025
- GDF15-GFRAL signaling drives weight loss and lipid metabolism in mouse model of amyotrophic lateral sclerosisBrain, Behavior, and Immunity, 2024
- Nucleocytoplasmic mRNA redistribution accompanies RNA binding protein mislocalization in ALS motor neurons and is restored by VCP ATPase inhibitionNeuron, 2023
- Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjectsNeuron, 2023
- ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of functionCell Reports, 2022
- G4C2 Repeat RNA Initiates a POM121-Mediated Reduction in Specific Nucleoporins in C9orf72 ALS/FTDNeuron, 2020
- Activation of the Notch Signaling Pathway and Cellular Localization of Notch Signaling Molecules in the Spinal Cord of SOD1-G93A ALS Model MiceNeuroscience, 2020
- Genome-wide Analyses Identify KIF5A as a Novel ALS GeneNeuron, 2018
- Axon guidance proteins: Novel therapeutic targets for ALS?Progress in Neurobiology, 2009
- The role of soluble intercellular adhesion molecules in neurodegenerative disordersJournal of the Neurological Sciences, 2005